OxyContin maker Purdue Pharma loses bid to delay opioid epidemic trial
March 08, 2019 at 19:15 PM EST
OxyContin maker Purdue Pharma LP and two other drugmakers on Friday lost a bid to delay a landmark trial set for May in a lawsuit by Oklahoma's attorney general accusing them of helping fuel an opioid abuse and overdose epidemic in the state.